The Western world's first gene therapy drug is set to go on sale in Germany with a 1.1 million euro ($1.4 million) price tag, a new record for a medicine to treat a rare disease.
bluebird bio
Breaking News
bluebird bio Inc. announced closing of its initial public offering after selling 6,832,352 shares priced at US$17 per share piece.
bluebird bio today announced the successful completion of a $60 million Series D financing.
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Tesla Shareholder Asks Judge to Prevent Elon Musk From Moving Pay Fight to Texas to Evade Delaware Ruling
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- Illinois Woman, Who Mysteriously Drowned After Giving $1.5 Million to Online Romance Scammers, Knew She'd 'End up Dead'
- Amazon Top Aggregator Thrasio Loses CEO, 5 Other Senior Execs Following Bankruptcy Filing
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
